Antihyperglycemic, Vasodilator, and Diuretic Activities of Microencapsulated Bioactive Product from Moringa stenopetala Leaves Extract

Table 2

Antihyperglycemic effects of microencapsulated bioactive product of M. stenopetala leaves extract.

Treatment groups	Fastened blood glucose level (mg/dl)
	1st day	7th day	14th day	21st day
Dose 500 mg/kg	337.60 ± 63.93^aA	329.90 ± 65.33^aB	319.90 ± 68.30^aB	281.80 ± 67.05^aB
Dose 750 mg/kg	271.10 ± 35.86^aA	257.40 ± 37.60^aAB	241.60 ± 37.32^aAB	228.20 ± 33.80^aAB
Dose 1000 mg/kg	300.20 ± 47.94^aA	263.60 ± 29.50^aAB	258.90 ± 48.17^aA	242.00 ± 47.41^aAB
Positive control	291.90 ± 51.95^aA	265.70 ± 51.07^aA	248.00 ± 49.03^aA	221.70 ± 48.08^aA
Negative control	223.90 ± 37.59^b	316.20 ± 31.68^a	330.70 ± 24.11^a	347.10 ± 36.06^a
Normal control	99.00 ± 5.70^a	99.20 ± 6.72^aC	98.20 ± 5.54^aC	98.20 ± 5.81^a

Superscript letters with small letters indicate the presence of significant differences () in a raw (in different days), whereas the capital letters indicate the presence of significant differences in a column (different doses of the microencapsulates and control groups).